Market capitalization | $2.41b |
Enterprise Value | $2.30b |
P/E (TTM) P/E ratio | 58.74 |
EV/FCF (TTM) EV/FCF | 68.74 |
EV/Sales (TTM) EV/Sales | 10.81 |
P/S ratio (TTM) P/S ratio | 11.30 |
P/B ratio (TTM) P/B ratio | 7.27 |
Dividend yield | 0.60% |
Last dividend (FY24) | $0.64 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
10 Analysts have issued a LeMaitre Vascular, Inc. forecast:
10 Analysts have issued a LeMaitre Vascular, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 213 213 |
15%
15%
|
|
Gross Profit | 140 140 |
23%
23%
|
|
EBITDA | 59 59 |
36%
36%
|
EBIT (Operating Income) EBIT | 50 50 |
45%
45%
|
Net Profit | 41 41 |
52%
52%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
Head office | United States |
CEO | George LeMaitre |
Employees | 630 |
Founded | 1983 |
Website | www.lemaitre.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.